Sign Up to like & get
recommendations!
0
Published in 2019 at "JAMA Psychiatry"
DOI: 10.1001/jamapsychiatry.2018.2734
Abstract: Importance Countering depressive disorders is a public health priority. Currently, antidepressants are the first-line treatment, although they show modest effects. In men, testosterone treatment is a controversial alternative or adjunct treatment option. Objectives To examine…
read more here.
Keywords:
testosterone treatment;
depressive symptoms;
treatment;
symptoms men ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "European urology focus"
DOI: 10.1016/j.euf.2017.10.016
Abstract: CONTEXT Testosterone replacement therapy (TRT) is currently approved by the Food and Drug Administration only for classic hypogonadism, although off-label indications have resulted in a dramatic expansion in prescriptions in the USA. Marketing may significantly…
read more here.
Keywords:
marketing testosterone;
testosterone treatment;
testosterone;
trt prescriptions ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Fertility and sterility"
DOI: 10.1016/j.fertnstert.2021.03.009
Abstract: OBJECTIVE To study the feasibility of in vitro maturation of ovarian tissue oocytes for fertility preservation in transgender men on testosterone treatment. DESIGN Cross-sectional study SETTING: University hospital PATIENT(S): Eighty-three transgender men enrolled from November 2015…
read more here.
Keywords:
testosterone treatment;
ovarian tissue;
transgender men;
rate ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Andrologia"
DOI: 10.1111/and.12768
Abstract: To alleviate late‐onset hypogonadism, testosterone treatment is offered to suitable patients. Although testosterone treatment is commonly given to late‐onset hypogonadism patients, there remains uncertainty about the metabolic effects during follow‐ups. We assessed the associations between…
read more here.
Keywords:
testosterone treatment;
liver enzymes;
testosterone;
blood ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Andrologia"
DOI: 10.1111/and.14628
Abstract: Congenital hypogonadotropic hypogonadism (CHH) is a rare disease caused by deficiency or action of gonadotropin‐releasing hormone. While generally considered a long‐life condition, CHH can be reversible in about 5%–20% of cases, but mechanisms of reversibility…
read more here.
Keywords:
testosterone treatment;
hypogonadism;
congenital hypogonadotropic;
testosterone ... See more keywords